Stock Fundamentals

Company Information

Company Name
Royalty Pharma Plc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: GB00BMVP7Y09
CIK: 0001802768
CUSIP: 76028H100
Currency: USD
Full Time Employees: 100
Phone: 212 883 0200
Fiscal Year End: December
IPO Date: Mar 25, 1993
Description:

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.

Address:

110 East 59th Street, New York, NY, United States, 10022

Directors & Officers

Name Title Year Born
Mr. Pablo Legorreta Founder, Chairman of the Board & CEO 1963
Mr. Terrance P. Coyne Executive VP & CFO NA
Mr. Christopher Hite Chairman of Partnering & Investments 1967
Dr. Marshall Jonathan Urist M.D., Ph.D. Executive Vice President of Research & Investments 1976
Mr. Eric Cornelius Schneider Senior VP & Chief Technology Officer NA
Dr. James Folmar Reddoch Ph.D. Executive VP of Investments & Chief Scientific Officer 1970
Mr. Arthur Richard McGivern J.D. Executive VP of Investment & Chief Legal Officer 1975
Ms. Molly Sawaya Executive VP & Head of Human Capital NA
Mr. Sandy Balkin Ph.D. Senior Vice President of Strategy & Analytics NA
Ms. Sara Klymkowsky Senior VP of Research & Investments NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 01, 2026 Terrance P Coyne N/A Sale 34.79K $48.33 $1.68M
Mar 23, 2026 Terrance P Coyne N/A Sale 34.79K $45.53 $1.58M
Mar 02, 2026 Terrance P Coyne N/A Sale 34.79K $46.78 $1.63M
Feb 04, 2026 Terrance P Coyne N/A Sale 20.16K $43.29 $872.86K
Feb 03, 2026 Terrance P Coyne N/A Sale 114.95K $42.84 $4.92M
Feb 02, 2026 Terrance P Coyne N/A Sale 108.42K $42.08 $4.56M
Jan 30, 2026 Marshall Urist N/A Sale 20.00K $41.09 $821.80K
Jan 23, 2026 Marshall Urist N/A Sale 20.00K $40.26 $805.20K
Jan 20, 2026 Terrance P Coyne N/A Sale 69.58K $39.35 $2.74M
Jan 16, 2026 Marshall Urist N/A Sale 20.00K $39.52 $790.40K
Jan 09, 2026 Marshall Urist N/A Sale 20.00K $40.78 $815.60K
Jan 02, 2026 Terrance P Coyne N/A Sale 69.58K $38.42 $2.67M
Dec 26, 2025 Marshall Urist N/A Sale 20.00K $39.32 $786.40K
Dec 19, 2025 Marshall Urist N/A Sale 20.00K $38.38 $767.60K
Dec 18, 2025 George W Lloyd N/A Sale 30.65K $38.50 $1.18M
Dec 17, 2025 George W Lloyd N/A Sale 79.35K $38.57 $3.06M
Dec 16, 2025 Marshall Urist N/A Sale 20.00K $38.32 $766.40K
Dec 15, 2025 Terrance P Coyne N/A Sale 69.58K $38.36 $2.67M
Dec 05, 2025 Marshall Urist N/A Sale 18.24K $39.15 $714.17K
Dec 05, 2025 Marshall Urist N/A Sale 23.33K $39.15 $913.53K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Morgan Stanley - Brokerage Accounts 43.57M Mar 31, 2026 9.81% $0.13 -21.17%
Capital Research & Mgmt Co - Division 3 35.01M Mar 31, 2026 7.88% $0.39 12.54%
BlackRock Inc 25.91M Mar 31, 2026 5.83% $0.02 -1.07%
FMR Inc 25.15M Mar 31, 2026 5.66% $0.06 -4.26%
Baillie Gifford & Co Limited. 16.16M Mar 31, 2026 3.64% $0.79 -5.02%
Swedbank AB 11.59M Mar 31, 2026 2.61% $0.58 -2.98%
State Street Corp 10.99M Mar 31, 2026 2.47% $0.02 3.19%
Vanguard Group Inc 9.93M Dec 31, 2025 2.24% $0.01 -9.16%
Capital World Investors 8.04M Mar 31, 2026 1.81% $0.05 0.00%
Geode Capital Management, LLC 7.87M Mar 31, 2026 1.77% $0.02 1.94%
Adage Capital Partners Gp LLC 7.48M Mar 31, 2026 1.68% $0.55 -36.28%
Caledonia (Private) Investments Pty Ltd 7.17M Mar 31, 2026 1.61% $10.00 -2.83%
Victory Capital Management Inc. 3.85M Mar 31, 2026 0.87% $0.12 -24.54%
Northern Trust Corp 3.81M Mar 31, 2026 0.86% $0.02 -4.86%
Royal London Asset Management Ltd 3.81M Mar 31, 2026 0.86% $0.38 2,019.48%
AQR Capital Management LLC 3.78M Mar 31, 2026 0.85% $0.08 47.53%
Amvescap Plc. 3.75M Mar 31, 2026 0.84% $0.03 149.80%
Patients Capital Management LLC 3.64M Mar 31, 2026 0.82% $6.39 9.30%
Bank of America Corp 3.50M Mar 31, 2026 0.79% $0.01 29.05%
NORGES BANK 3.41M Dec 31, 2025 0.77% $0.01 -32.18%

Shares Statistics

Shares Outstanding: 443.27M
Shares Float: 410.36M
% Insiders: 716.30%
% Institutions: 8,578.50%
Short % Float: 2.90%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 American Funds New Perspective A 19.65M 4.42% ▲ 94.71% Mar 31, 2026
2 Capital Group New Perspective Comp 19.65M 4.42% ▲ 94.71% Mar 31, 2026
3 American Funds Capital Income Bldr A 8.58M 1.93% ▲ 401.37% Mar 31, 2026
4 Capital Group Growth Fnd of Amer Comp 6.41M 1.44% ▲ 46.21% Mar 31, 2026
5 American Funds Growth Fund of Amer A 6.41M 1.44% ▲ 46.21% Mar 31, 2026
6 MS INVF US Advantage I 5.57M 1.25% ▲ 0.00% Apr 30, 2026
7 Morgan Stanley Growth SMA 5.21M 1.17% ▼ 5.34% Mar 31, 2026
8 Morgan Stanley Growth 5.21M 1.17% ▼ 5.34% Mar 31, 2026
9 Morgan Stanley Inst Growth I 5.21M 1.17% ▼ 5.34% Mar 31, 2026
10 Vanguard Institutional Extnd Mkt Idx Tr 4.25M 0.96% ▲ 1.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $32.03B
Trailing P/E: 28.93
Forward P/E: 45.66

Financial Highlights

Market Cap: $31.65B
EBITDA: $1.56B
P/E Ratio: $28.93
PEG Ratio: $2.06
Book Value: $15.53
Dividend/Share: $0.90
Dividend Yield: 1.66%
Earnings/Share: $1.90
Profit Margin: 33.86%
Operating Margin: 100.30%
ROA (TTM): 5.54%
ROE (TTM): 13.77%
Revenue (TTM): $2.44B
Revenue/Share (TTM): $5.67
Earnings Growth (YOY): 23.20%
Revenue Growth (YOY): 11.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 0.97x 1.38x 0.50x 5.07x 5.47x
2024-12-31 1.44x 1.10x 0.43x 5.73x 4.89x
2023-12-31 7.90x 0.94x 0.38x 7.97x 3.25x
2022-12-31 2.19x 1.26x 0.43x 1.63x 16.80x
2021-12-31 16.81x 1.36x 0.41x 8.61x 9.78x
2020-12-31 8.76x 0.41x 0.29x 10.16x 3.24x
2019-12-31 2.50x 1.02x 0.51x 9.77x 2.27x
2018-12-31 4.50x 1.45x 0.60x 4.87x 3.56x
2017-12-31 7.69x 0.06x 0.61x 3.80x 0.17x
2016-12-31 10.10x 0.04x 0.57x 3.03x 0.16x
2015-12-31 9.68x 0.04x 0.57x 3.54x 0.21x
2014-12-31 16.04x 0.00x 0.06x N/A 0.00x
2013-12-31 0.00x 0.00x 0.04x N/A N/A
2012-12-31 0.00x 0.00x 0.14x N/A N/A
2011-12-31 0.00x 0.00x 0.23x N/A N/A
2010-12-31 0.00x 0.00x 0.29x N/A N/A
2009-12-31 0.00x 0.00x 0.81x N/A N/A
2008-12-31 0.00x 0.00x 0.31x N/A N/A
2007-12-31 0.00x 0.00x 0.13x N/A N/A
2006-12-31 0.00x 0.00x 0.52x N/A N/A
2005-12-31 0.00x 0.00x 0.04x N/A N/A
2004-12-31 0.00x 0.00x 0.09x N/A N/A
2003-12-31 0.00x 0.00x 0.02x N/A N/A
2002-12-31 0.00x 0.00x 0.02x N/A N/A
2001-12-31 0.00x 0.00x 0.17x N/A N/A
2000-12-31 0.00x 0.00x 0.23x N/A N/A

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about RPRX.US!